[go: up one dir, main page]

IL96043A0 - Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known - Google Patents

Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known

Info

Publication number
IL96043A0
IL96043A0 IL96043A IL9604390A IL96043A0 IL 96043 A0 IL96043 A0 IL 96043A0 IL 96043 A IL96043 A IL 96043A IL 9604390 A IL9604390 A IL 9604390A IL 96043 A0 IL96043 A0 IL 96043A0
Authority
IL
Israel
Prior art keywords
peptides
proteins
amino acid
acid sequence
nucleotide coding
Prior art date
Application number
IL96043A
Other languages
English (en)
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/708,001 external-priority patent/US4863857A/en
Application filed by Univ Texas filed Critical Univ Texas
Publication of IL96043A0 publication Critical patent/IL96043A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in epitope analysis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/695Corticotropin [ACTH]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/803Physical recovery methods, e.g. chromatography, grinding

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
IL96043A 1985-03-01 1990-10-17 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known IL96043A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/708,001 US4863857A (en) 1985-03-01 1985-03-01 Polypeptide complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
US06/829,709 US5077195A (en) 1985-03-01 1986-02-19 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known and methods of design therefor

Publications (1)

Publication Number Publication Date
IL96043A0 true IL96043A0 (en) 1991-07-18

Family

ID=27108003

Family Applications (1)

Application Number Title Priority Date Filing Date
IL96043A IL96043A0 (en) 1985-03-01 1990-10-17 Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known

Country Status (18)

Country Link
US (2) US5077195A (es)
EP (2) EP0332225B1 (es)
JP (1) JPH07215999A (es)
KR (1) KR920002315B1 (es)
AT (2) ATE88572T1 (es)
AU (1) AU592781B2 (es)
BR (1) BR8606615A (es)
CA (1) CA1339606C (es)
DE (2) DE3688333T2 (es)
DK (1) DK521386A (es)
ES (3) ES8705919A1 (es)
FI (1) FI90255C (es)
GR (1) GR860576B (es)
IE (1) IE58837B1 (es)
IL (1) IL96043A0 (es)
NO (1) NO174971C (es)
PT (1) PT82132B (es)
WO (1) WO1986005208A1 (es)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1986002666A1 (en) * 1984-10-29 1986-05-09 Microgenics Corporation Methods for protein binding enzyme complementation assays
DE3527568A1 (de) * 1985-08-01 1987-02-05 Bissendorf Peptide Gmbh Synthetische peptidrezeptoren, verfahren zur herstellung und verwendung derselben
CA1297003C (en) * 1985-09-20 1992-03-10 Jack H. Nunberg Composition and method for treating animals
WO1987005029A2 (en) * 1986-02-19 1987-08-27 Triton Biosciences Inc Peptides affecting blood pressure regulation
US4772684A (en) * 1987-01-20 1988-09-20 Triton Biosciences, Inc. Peptides affecting blood pressure regulation
EP0331184A3 (en) * 1988-03-04 1991-05-08 The Board Of Trustees Of The University Of Alabama For Its Division University Of Alabama In Birmingham Peptide equivalents of non-peptides and methods of design therefor
ATE187738T1 (de) * 1989-07-31 2000-01-15 Tecnogen Scpa Verfahren zur identifizierung und herstellung von bindungsstellen aufeinanderwirkender proteine
US5324512A (en) * 1990-12-26 1994-06-28 The Population Council [Gln']-luteinizing hormone releasing hormone conjugate of tetanus vaccine and its uses
JPH05262788A (ja) * 1991-09-03 1993-10-12 Hitachi Chem Co Ltd ペプチド類、その設計方法及び製造方法並びに受容体上の生理活性ペプチドの結合部位の決定方法
US5620675A (en) 1992-06-23 1997-04-15 Diatech, Inc. Radioactive peptides
US6017512A (en) * 1992-06-23 2000-01-25 Diatide, Inc. Radiolabeled peptides
RU2145976C1 (ru) * 1993-10-04 2000-02-27 Сумитомо Кемикал Компани, Лимитед Способ получения полипептида (варианты)
EP0672421B1 (en) * 1993-10-07 2002-03-20 Kurashiki Boseki Kabushiki Kaisha Endothelin activity inhibitor
US6051206A (en) * 1994-06-03 2000-04-18 Diatide, Inc Radiolabeled somatostatin-derived peptides for imaging and therapeutic uses
IL115177A0 (en) * 1994-09-16 1995-12-31 Immunomedics Inc Phosphorus-32 labeling of antibodies for cancer therapy
US5523208A (en) * 1994-11-30 1996-06-04 The Board Of Trustees Of The University Of Kentucky Method to discover genetic coding regions for complementary interacting proteins by scanning DNA sequence data banks
JP3737516B2 (ja) * 1995-06-26 2006-01-18 パーセプティブ バイオシステムズ,インコーポレーテッド 高速自動化連続流、多次元分子選別および分析
US5807552A (en) * 1995-08-04 1998-09-15 Board Of Regents, The University Of Texas System Compositions for conferring immunogenicity to a substance and uses thereof
DK1039931T3 (da) * 1997-12-01 2005-08-08 Fang Fang Multivalente rekombinante antistoffer til at behandle HRV infektioner
DE19805334A1 (de) * 1998-02-11 1999-08-12 Otogene Biotechnologische Fors Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes
CA2350163A1 (en) * 1998-04-24 1999-11-04 Fang Fang Identifying peptide ligands of target proteins with target complementary library technology (tclt)
US20030035798A1 (en) * 2000-08-16 2003-02-20 Fang Fang Humanized antibodies
DE60040623D1 (de) * 1999-03-09 2008-12-04 Fornix Biosciences N V Komplementäre, synthetische peptide und ihre nutzung in der ophthalmologie
GB2356401A (en) * 1999-11-19 2001-05-23 Proteom Ltd Method for manipulating protein or DNA sequence data
GB9929469D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from plant genomes
GB9929466D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligands generated from microbial genome sequences
GB9929464D0 (en) * 1999-12-13 2000-02-09 Proteom Ltd Complementary peptide ligande generated from the human genome
WO2002027313A1 (en) * 2000-09-26 2002-04-04 Geneformatics, Inc. Methods for determining aproximations of three dimensional polypeptide structure
GB0025251D0 (en) * 2000-10-14 2000-11-29 Proteom Ltd Antisense peptides to Fc receptors and their uses
EP1362093B1 (en) * 2001-02-20 2010-11-17 University Of Georgia Research Foundation, Inc. Rapid production of monoclonal antibodies
AU2002365196C1 (en) 2001-07-19 2009-08-13 Perlan Therapeutics, Inc. Multimeric proteins and methods of making and using same
RU2422458C2 (ru) * 2006-03-23 2011-06-27 Кьюравак, Инк. Комплементарный пептид к основному иммуногенному району рецептора ацетилхолина, терапевтическая композиция на его основе, способ изготовления пептида и его применение
US8227583B2 (en) 2007-06-14 2012-07-24 The Board Of Regents For Oklahoma State University Vaccines containing canine parvovirus genetic variants
RU2519210C2 (ru) * 2007-06-14 2014-06-10 Дзе Борд Оф Риджентс Фор Оклахома Стейт Юниверсити Вакцины, содержащие генетические варианты парвовируса собак
WO2019046634A1 (en) * 2017-08-30 2019-03-07 Peption, LLC METHOD FOR GENERATING INTERACTIVE PEPTIDES

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes

Also Published As

Publication number Publication date
EP0214232A1 (en) 1987-03-18
DK521386A (da) 1986-12-29
DE3688333D1 (de) 1993-05-27
ATE63138T1 (de) 1991-05-15
DE3679017D1 (de) 1991-06-06
IE58837B1 (en) 1993-11-17
FI864427A0 (fi) 1986-10-30
WO1986005208A1 (en) 1986-09-12
AU592781B2 (en) 1990-01-25
NO864369L (no) 1987-01-02
KR920002315B1 (ko) 1992-03-21
DK521386D0 (da) 1986-10-31
NO864369D0 (no) 1986-10-31
ATE88572T1 (de) 1993-05-15
CA1339606C (en) 1997-12-30
DE3688333T2 (de) 1993-10-28
GR860576B (en) 1986-07-01
KR870700100A (ko) 1987-02-28
FI90255B (fi) 1993-09-30
NO174971B (no) 1994-05-02
EP0214232B1 (en) 1991-05-02
AU5510286A (en) 1986-09-24
JPH07215999A (ja) 1995-08-15
ES8800267A1 (es) 1987-11-01
BR8606615A (pt) 1987-08-11
US5077195A (en) 1991-12-31
ES8800266A1 (es) 1987-11-01
ES552534A0 (es) 1987-05-16
ES8705919A1 (es) 1987-05-16
NO174971C (no) 1994-08-10
EP0332225A2 (en) 1989-09-13
IE860527L (en) 1986-09-01
PT82132B (pt) 1989-05-31
FI864427A7 (fi) 1986-10-30
ES557188A0 (es) 1987-11-01
EP0332225B1 (en) 1993-04-21
ES557189A0 (es) 1987-11-01
EP0332225A3 (en) 1989-09-27
PT82132A (en) 1986-04-01
FI90255C (fi) 1994-01-10
US5212072A (en) 1993-05-18

Similar Documents

Publication Publication Date Title
IL96043A0 (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
DE3856560D1 (de) Dem menschlichen gewebefaktor ähnliche dns-segmente, polypeptide und antikörper
PL393286A1 (pl) Rozpuszczalny receptor BR43x2 i sposoby jego zastosowania
GB2183661B (en) Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique
IL89541A0 (en) Urethane-protected amino acid-n-carboxyanhydrides and their use in the synthesis of polypeptides
AU1056188A (en) Immunoaffinity purification system
NZ527053A (en) Modified amyloid precursor protein polynucleotides and polypeptides
KR970702917A (ko) Lag-3의 가용성 폴리펩타이드 절편 및 생산 방법, 치료 조성물, 항-이디오타입 항체
EP0150735A3 (en) Method and composition for preparation of factor viiic
ATE189684T1 (de) Rekombinante polypeptide und peptide, dafür kodierende nukleinsäuren und ihre verwendung in der tuberkulose-diagnose
ZA861482B (en) Polypeptides complementary to peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known
GR3035099T3 (en) Corpuscles of stannius protein, stanniocalcin
CA2021722A1 (en) Variant proteins and polypeptides possessing enhanced affinity for immobilized-metal affinity matrices
AU2676399A (en) Novel cystine knot protein and materials and methods for making it
AU1444699A (en) Single-chain polypeptides comprising troponin i and troponin
EP0502553A3 (en) Peptide fragment from human villin and antibody thereto
Roholt et al. A light chain tyrosyl sequence in the antibody site of a rabbit anti-p-azobenzoate antibody
ATE317851T1 (de) Polypeptide mit aminosäuresequenzen aus dem n- terminalen bereich von gp116 von cytomegalovirus und deren verwendung bei der diagnostik, prophylaxe und therapie
IL96043A (en) Polypeptides having binding affinity for peptides or proteins having an amino acid sequence or nucleotide coding sequence at least partially known,the binding affinity being dependent on the carboxy-terminal and amino-terminal directionality of the polypeptides
Carrel et al. Studies on sheep anti-human IgG antibodies and their sub-units
NZ606260A (en) Novel polypeptides involved in immune response